High rates of HIV seropositivity in Africa - Alternative explanation [1]

International Journal of STD and AIDS

Volumn 14, Issue 6, 2003, Pages 426-427

  Papadopulos Eleopulos, Eleni ^a   Turner, Valendar F ^a   Papadimitriou, John M ^b   Alfonso, Helman ^d   Page, Barry A P ^a   Causer, David ^a   Mhlongo, Sam ^c   Fiala, Christian ^d   Brink, Anthony ^d  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c SEFAKO MAKGATHO HEALTH SCIENCES UNIVERSITY   (South Africa)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ANTIBODY SPECIFICITY; ERYTHROCYTE SEDIMENTATION RATE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; IMMUNOASSAY; INFECTION RATE; LETTER; PRIORITY JOURNAL; VERTICAL TRANSMISSION; VIRUS ISOLATION;

AFRICA SOUTH OF THE SAHARA; AIDS SERODIAGNOSIS; BLOTTING, WESTERN; HIV ANTIBODIES; HIV SEROPOSITIVITY; HIV SEROPREVALENCE; HUMANS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 0037712006     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646203765371330     Document Type: Letter

References (19)

1. Gisselquist D, Rothenberg R, Potterat J, Drucker E. HIV infections in sub-Saharan Africa not explained by sexual or vertical transmission. Int J STD AIDS 2002;13:657-66
2. Papadopulos-Eleopopulos E, Turner VF, Papadimitriou JM, Bialy H. AIDS in Africa: Distinguishing fact and fiction. World J Microbiol Biotechnol 1995;11:135-43
3. Papadoulos-Eleopulos E, Turner VF, Papadimitriou JM et al. Mother to child transmission of HIV and its prevention with AZT and nevirapine. Perth: The Perth Group, 2001
4. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM, et al. Global voices on HIV/AIDS. Heterosexual transmission of HIV in Africa is no higher than anywhere else. BMJ 2002;324:1035. http://bmj.com/cgi/content/full/324/7344 #resp3
5. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull WHO 1999;77:789-800
6. CDC. Fact sheet on HIV transmission. Fact sheet on HIV transmission 1994; January. www.cdc.gov/hiv/pubs/facts/transmission.htm
7. Blattner WA. Retroviruses. In: Evans AS, ed. Viral infections of humans. 3rd edn. New York: Plenum Medical Book Company. 1989:545-92
8. Mortimer PP. The AIDS virus and the AIDS test. Med Int 1989;56:2334-9
9. Abbott Laboratories. Human Immunodeficiency Virus Type-1. Qualitative Enzyme Immunoassay for the Detection of Antibody to Human Immunodeficiency Virus Type-1 (HIV-1) in Human Serum or Plasma. Abbott Laboratories, Diagnostics Division, 1988.
10. Kashala O, Marlink R, Ilunga M, et al. Infection with human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross-reactivity and antibodies to lipoarabinomannan to interpret. J Infect Dis 1994;169:296-304
11. Muller WEG, Bachmann M, Weiler BE, Schroder HC, Uhlenbruck GU, Shinoda T, et al. Antibodies against defined carbohydrate structures of Candida albicans protect H9 cells against infection with human immunodeficiency virus-1 in vitro. J Acquir Immun Defic Syndr 1991;4:694-703
12. Tomiyama T, Lake D, Masuho Y, Hersh EM. Recognition of human immunodeficiency virus glycoproteins by natural anti-carbohydrate antibodies in human serum. Biochem Biophys Res Comm 1991;177:179-85
13. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM, Causer D. HIV antibodies: Further questions and a plea for clarification. Curr Med Res Opinion 1997;13:627-34
14. Mother-to-child transmission of HIV infection. The European Collaborative Study. Lancet 1988;ii:1039-43
15. Parekh BS, Shaffer N, Coughlin R, et al. Dynamics of maternal IgG antibody decay and HIV-specific antibody synthesis in infants born to seropositive mothers. The NYC Perinatal HIV Transmission Study Group. AIDS Res Hum Retrovir 1993;9:907-12
16. Papadopulos-Eleopulos E, Turner VF, Papadimitriou JM. Is a positive Western blot proof of HIV infection? Bio/Technology 1993;11:696-707
17. Dondero TJ, Curran JW. Excess deaths in Africa from HIV: confirmed and quantified. Lancet 1994;343:989
18. Mulder DW, Nunn AJ, Kamali A, Nakylingi J, Wagner HU, Kengeya-Kayondo JF. Two-year HIV-1-associated mortality in a Ugandan rural population. Lancet 1994;343:1021-3
19. Lefrere JJ, Salmon D, Doinel C, et al. Sedimentation rate as a predictive marker in HIV infection. AIDS 1988;2:63-4